Piperacillin Sodium is the sodium salt form of Piperacillin, a semi-synthetic, extended spectrum fungistatic β-lactam fourth-generation ureidopenicillin. Derived from Ampicillin, Piperacillin was developed by Toyama Chemical Co, Tokyo, Japan. It can also be used to study multidrug resistance.
Piperacillin Sodium is freely soluble in aqueous solution.
We also offer:
- Piperacillin (P017)
|Mechanism of Action||β-lactams interfere with PBP (penicillin binding protein) activity involved in the final phase of peptidoglycan synthesis. PBP’s are enzymes which catalyze a pentaglycine crosslink between alanine and lysine residues providing additional strength to the cell wall. Without a pentaglycine crosslink, the integrity of the cell wall is severely compromised and ultimately leads to cell lysis and death. Resistance to β-lactams is commonly due to cells containing plasmid encoded β-lactamases.|
|Spectrum||Piperacillin is a broad-spectrum antibiotic targeting a wide range of susceptible Gram-positive and Gram-negative bacteria. It targets both aerobic and anaerobic bacteria. It can be used against Enterococcus species, Pseudomonas aeruginosa, and E. coli.|
|Impurity Profile||Chromatographic Impurities:
Piperacillin Related Compound A: ≤ 3.5%
Piperacillin Related Compound C: ≤ 1.0%
|Microbiology Applications||Piperacillin is commonly used in clinical in vitro microbiological antimicrobial susceptibility tests (panels, discs, and MIC strips) against Gram-positive and Gram-negative microbial isolates. It is commonly used in a mixture with the beta-lactamase inhibitor Tazobactam which enhances is effectiveness. Medical microbiologists use AST results to recommend antibiotic treatment options. Representative MIC ranges include:
For a representative list of Piperacillin MIC values, click here.
|Plant Biology Applications||In vitro antibacterial activity of Piperacillin against Agrobacterium tumefaciens strains LBA4404 and EHA101 was examined and found to be effective in eliminating the bacteria involved in Agrobacterium-mediated plant genetic transformation (Ogawa and Mii, 2004).|
Ida K, Hirata S, Nakamuta S and Koike M (1978) Inhibition of cell division of Escherichia coli by a new synthetic penicillin, Piperacillin. Antimicrob. Agents. Chemother. 14 (2) 257-266
Karlowsky J et al (2003) Comparison of four antimicrobial susceptibility testing methods to determine the in vitro activities of Piperacillin and Piperacillin-Tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa. J. Clin. Microbiol 41(7):3339-3343